Literature DB >> 17943553

Silymarin enhanced cytotoxic effect of anti-Fas agonistic antibody CH11 on A375-S2 cells.

Lin-Hao Li1, Li-Jun Wu, Yuan-Yuan Jiang, Shin-Ichi Tashiro, Satoshi Onodera, Fumiaki Uchiumi, Takashi Ikejima.   

Abstract

Silymarin is a polyphenolic flavonoid from milk thistle (Silybum marianum), which has anti-inflammatory, cytoprotective as well as antioxidant effects. Our previous study demonstrated that silymarin has anti-apoptotic effect against UV irradiation. In this study, we assessed the effect of silymarin on anti-Fas agonistic antibody CH11-treated human malignant melanoma, A375-S2 cells. Pretreatment with silymarin (3 x 10(- 4) mol/L) significantly induced cell apoptosis in CH11-treated A375-S2 cells. Mitochondrial transmembrane potential (DeltaPsi(m)) was also down-regulated by silymarin pretreatment. Caspase-8, -9, -3 and pan-caspase inhibitors partially reversed silymarin-induced apoptosis of CH11-treated cells. The expression of Fas-associated proteins with death domain (FADD), a downstream molecule of the death receptor pathway, was increased by silymarin pretreatment, followed by cleavage of procaspase-8, whose activation induced cell apoptosis. Moreover, cleavage of procaspase-3 and digestion of its substrate, the inhibitor of caspase-activated DNase (ICAD), were also increased by silymarin pretreatment. These results suggested that silymarin could also exaggerate the apoptotic effect of anti-Fas agonistic antibody CH11 on A375-S2 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943553     DOI: 10.1080/10286020600882502

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  13 in total

Review 1.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 2.  Botanicals for the prevention and treatment of cutaneous melanoma.

Authors:  Deeba N Syed; Hasan Mukhtar
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-12       Impact factor: 4.693

Review 3.  Targeting drivers of melanoma with synthetic small molecules and phytochemicals.

Authors:  Leah Ray Strickland; Harish Chandra Pal; Craig A Elmets; Farrukh Afaq
Journal:  Cancer Lett       Date:  2015-01-15       Impact factor: 8.679

Review 4.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

Review 5.  Novel molecules as the emerging trends in cancer treatment: an update.

Authors:  Priyanka Sekar; Raashmi Ravitchandirane; Sofia Khanam; Nethaji Muniraj; Ananda Vayaravel Cassinadane
Journal:  Med Oncol       Date:  2022-01-04       Impact factor: 3.064

6.  Silibinin relieves UVB-induced apoptosis of human skin cells by inhibiting the YAP-p73 pathway.

Authors:  Wei-Wei Liu; Fang Wang; Can Li; Xiao-Yu Song; Wuxiyar Otkur; Yu-Ying Zhu; Toshihiko Hayashi; Kazunori Mizuno; Shunji Hattori; Hitomi Fujisaki; Takashi Ikejima
Journal:  Acta Pharmacol Sin       Date:  2021-12-15       Impact factor: 7.169

Review 7.  Multitargeted therapy of cancer by silymarin.

Authors:  Kumaraguruparan Ramasamy; Rajesh Agarwal
Journal:  Cancer Lett       Date:  2008-05-09       Impact factor: 8.679

Review 8.  Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility.

Authors:  Monica Marzagalli; Marina Montagnani Marelli; Lavinia Casati; Fabrizio Fontana; Roberta Manuela Moretti; Patrizia Limonta
Journal:  Front Endocrinol (Lausanne)       Date:  2016-10-26       Impact factor: 5.555

9.  "Silymarin", a promising pharmacological agent for treatment of diseases.

Authors:  Gholamreza Karimi; Maryam Vahabzadeh; Parisa Lari; Marziyeh Rashedinia; Mohammad Moshiri
Journal:  Iran J Basic Med Sci       Date:  2011-07       Impact factor: 2.699

10.  Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.

Authors:  Michal Bijak; Ewelina Synowiec; Przemyslaw Sitarek; Tomasz Sliwiński; Joanna Saluk-Bijak
Journal:  Nutrients       Date:  2017-12-14       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.